| pubmed-article:12637464 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C1100184 | lld:lifeskim |
| pubmed-article:12637464 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:12637464 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12637464 | pubmed:dateCreated | 2003-3-14 | lld:pubmed |
| pubmed-article:12637464 | pubmed:abstractText | To select a daily dose of arzoxifene (LY353381), a selective estrogen receptor modulator, for use in future studies in women with locally advanced or metastatic breast cancer who are either potentially tamoxifen sensitive (TS) or tamoxifen refractory (TR). | lld:pubmed |
| pubmed-article:12637464 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12637464 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12637464 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12637464 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12637464 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:WinerEricE | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:O'Shaughnessy... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:MunsterPamela... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:HudisClifford... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:BooserDaniel... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:JonesStephen... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:BuzdarAmanA | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:PetersonPatri... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:PippenJohn... | lld:pubmed |
| pubmed-article:12637464 | pubmed:author | pubmed-author:MelemedAllen... | lld:pubmed |
| pubmed-article:12637464 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12637464 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:12637464 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:12637464 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12637464 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12637464 | pubmed:pagination | 1007-14 | lld:pubmed |
| pubmed-article:12637464 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:meshHeading | pubmed-meshheading:12637464... | lld:pubmed |
| pubmed-article:12637464 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12637464 | pubmed:articleTitle | Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer. | lld:pubmed |
| pubmed-article:12637464 | pubmed:affiliation | M.D. Anderson Cancer Center and US Oncology Research, Houston, and Baylor-Sammons Cancer Center and Texas Oncology, Dallas, TX. 77030, USA. abuzdar@mdanderson.org | lld:pubmed |
| pubmed-article:12637464 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12637464 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12637464 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12637464 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12637464 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12637464 | lld:pubmed |
